Director Julia A. Haller filed a Form 4 with the SEC on November 6, 2026, disclosing a sale of Bristol Myers Squibb common stock on November 5, 2026.

Key Highlights

  • Reporting person: Julia A. Haller, listed as a Director of Bristol Myers Squibb Co (NYSE:BMY)
  • Transaction: 3,800 shares of Common Stock ($0.10 par value) disposed of, transaction code "S" (sale)
  • Sale price: $63.31 per share
  • Transaction date: November 5, 2026
  • Remaining ownership: 30,279 shares beneficially owned directly following the transaction
  • No derivative securities were reported as acquired, disposed of, or beneficially owned

Director Haller's November 2026 Share Disposition at Bristol Myers Squibb

According to the filing, Julia A. Haller, identified as a Director of Bristol Myers Squibb Co (NYSE:BMY), reported the disposition of 3,800 shares of the company's Common Stock, $0.10 par value, on November 5, 2026. The transaction was recorded under code "S," indicating an open-market sale, at a price of $63.31 per share. The form was signed by Amy Fallone as attorney-in-fact for Julia Haller, M.D., and filed on November 6, 2026.

Following the reported transaction, the filing states that Haller directly beneficially owned 30,279 shares of Bristol Myers Squibb common stock. No indirect ownership or derivative securities positions were reported in Table II of the filing. The form does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox was not checked.

The filing was submitted as an individual filing by one reporting person and does not reflect any amendment to a previously filed Form 4, according to the disclosure.

What Was Disclosed

The filing disclosed that Director Julia A. Haller sold 3,800 shares of Bristol Myers Squibb common stock at $63.31 per share on November 5, 2026, leaving her with a direct beneficial ownership of 30,279 shares following the transaction.